These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 31837949)

  • 1. p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling.
    Piipponen M; Nissinen L; Riihilä P; Farshchian M; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
    Am J Pathol; 2020 Feb; 190(2):503-517. PubMed ID: 31837949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
    Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity.
    Piipponen M; Nissinen L; Farshchian M; Riihilä P; Kivisaari A; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
    J Invest Dermatol; 2016 Aug; 136(8):1701-1710. PubMed ID: 27049681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
    Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
    Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC00346 promotes hepatocellular carcinoma progression via activating the JAK-STAT3 signaling pathway.
    Yin YZ; Zheng WH; Zhang X; Chen YH; Tuo YH
    J Cell Biochem; 2020 Jan; 121(1):735-742. PubMed ID: 31478228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA SCARNA2 induces cutaneous squamous cell carcinoma progression via modulating miR-342-3p expression.
    Zhang Z; Jia M; Wen C; He A; Ma Z
    J Gene Med; 2020 Dec; 22(12):e3242. PubMed ID: 32558970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
    Wu N; Hui H; Cui L; Yang F
    Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway.
    Liu Z; Li H; Fan S; Lin H; Lian W
    Cancer Biol Ther; 2019; 20(4):444-453. PubMed ID: 30404566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma.
    Li F; Liao J; Duan X; He Y; Liao Y
    J Cell Biochem; 2018 Dec; 119(12):10393-10405. PubMed ID: 30145798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR‑138‑5p in cutaneous squamous cell carcinoma.
    Zou S; Gao Y; Zhang S
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USF1-induced upregulation of LINC01048 promotes cell proliferation and apoptosis in cutaneous squamous cell carcinoma by binding to TAF15 to transcriptionally activate YAP1.
    Chen L; Chen Q; Kuang S; Zhao C; Yang L; Zhang Y; Zhu H; Yang R
    Cell Death Dis; 2019 Apr; 10(4):296. PubMed ID: 30931936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WW domain-containing E3 ubiquitin protein ligase 1 depletion evokes antitumor effect in cutaneous squamous cell carcinoma by inhibiting signal transducer and activator of transcription 3 signaling pathway.
    Xia Y; Chang X; Lian S; Zhu W
    J Int Med Res; 2018 Jul; 46(7):2898-2912. PubMed ID: 29888632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-mRNA processing factor 3 enhances the progression of keratinocyte-derived cutaneous squamous cell carcinoma by regulating the JAK2/STAT3 pathway.
    Zuo S; Li X; Bao W; Li S
    Sci Rep; 2020 Jun; 10(1):8863. PubMed ID: 32483193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA WT1-AS up-regulates p53 to inhibit the proliferation of cervical squamous carcinoma cells.
    Zhang Y; Na R; Wang X
    BMC Cancer; 2019 Nov; 19(1):1052. PubMed ID: 31694597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway.
    Lu D; Sun L; Li Z; Mu Z
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Toriseva M; Kivisaari A; Ala-Aho R; Kallajoki M; Veräjänkorva E; Honkanen HK; Heljasvaara R; Pihlajaniemi T; Grénman R; Peltonen J; Peltonen S; Kähäri VM
    J Invest Dermatol; 2015 Jul; 135(7):1882-1892. PubMed ID: 25789706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells.
    Zhang W; Zhou K; Zhang X; Wu C; Deng D; Yao Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
    Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-125b exerts antitumor functions in cutaneous squamous cell carcinoma by targeting the STAT3 pathway.
    Tian K; Liu W; Zhang J; Fan X; Liu J; Zhao N; Yao C; Miao G
    Cell Mol Biol Lett; 2020; 25():12. PubMed ID: 32161621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.
    Riihilä PM; Nissinen LM; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
    J Invest Dermatol; 2014 Feb; 134(2):498-506. PubMed ID: 23938460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.